Anebulo Pharmaceuticals, Inc. (ANEB)

Price & Market Data

Price: $0.52

Daily Change: $0.00 / 0.00%

Daily Range: $0.52 - $0.52

Market Cap: $21,208,058

Daily Volume: 100

Performance Metrics

1 Week: 3.66%

1 Month: -10.34%

3 Months: 10.59%

6 Months: -77.78%

1 Year: -46.94%

YTD: -48.51%

About Anebulo Pharmaceuticals, Inc. (ANEB)

Analyze the market position of Anebulo Pharmaceuticals, Inc. (ANEB). With a current price of 0.52, the stock exhibits a $0.00 / 0.00% daily trend. A market capitalization of 21,208,058 indicates its scale. Discover its performance over 1-month (-10.34%) and 3-month (10.59%) periods.

Company Details

Employees: 3

Sector: Health technology

Industry: Pharmaceuticals: major

Country: United States

Details

Anebulo Pharmaceuticals, Inc., a clinical-stage biotechnology company, engages in developing treatments for unintentional cannabis poisoning, acute cannabinoid intoxication, and acute cannabis-induced conditions in the United States. The company's lead product candidate is the selonabant, a small-molecule antagonist of cannabinoid binding receptor type-1(CB1), which is in a phase II clinical trial to address the unmet medical need for a specific antidote for cannabis toxicity. Anebulo Pharmaceuticals, Inc. was incorporated in 2020 and is headquartered in Lakeway, Texas.

Selected stocks

Patagonia Gold Corp. (HGLD)

Grupo Financiero Inbursa, S.A. de C.V. (GPFOF)

Gem Diamonds Ltd. (GMDMF)

Var Energi ASA (VARRY)

Big Screen Entertainment Group, Inc. (BSEG)